Analysis of Candidate Modifier Loci for the Severity of Colonic Familial Adenomatous Polyposis, with Evidence for the Importance of the N-acetyl Transferases

Overview

Journal Gut

Specialty Gastroenterology

Date 2004 Jan 16

PMID 14724163

Citations 20

Authors

M D Crabtree

C Fletcher

M Churchman

S V Hodgson

K Neale

R K S Phillips

I P M Tomlinson

Affiliations

Soon will be listed here.

Abstract

Background: We have recently shown that the severity of human colonic familial adenomatous polyposis (FAP) varies in a manner consistent with the action of modifier genes. These modifier genes may harbour common alleles which increase the risk of colorectal cancer (CRC) in the general population. Analyses have suggested several common polymorphisms as risk alleles for CRC.

Methods: We determined the association between the severity of colonic FAP (151 patients) and polymorphisms in MTHFR, NAT1, NAT2, GSTM, GSTT, cyclin D1, E-cadherin, and APC. All of these loci have been suggested as influencing the risk of CRC. Colonic FAP severity was quantitated as the number of polyps per colectomy specimen, standardised for colon size. We analysed the relationship between disease severity and genotype at the polymorphic site, making allowance for the position of the germline APC mutation.

Results: We identified significant associations between more severe disease and the absence of the NAT1*10 genotype in the whole group of patients. In a subset of patients with germline mutations in the so-called "mutation cluster region", there was an association between more severe disease and the presence of NAT2*fast alleles. In the whole patient set, a relatively strong association existed between more severe disease and possession of both the NAT1*non-10 and NAT2*fast genotypes. There was weak evidence for an association between the APCT1493C allele and more severe disease in the whole patient group. No consistent association with disease severity was found for the other polymorphisms.

Conclusion: The severity of colonic FAP may be modified by alleles at the NAT1 and/or NAT2 loci. The identity of any functional variation remains unknown as NAT1*10 appears to be non-functional and there is linkage disequilibrium between alleles at multiple sites within these loci which are adjacent on chromosome 8p22. While evidence from this study cannot be conclusive, our data suggest that NAT1 and NAT2 variants may explain an approximately twofold increase in polyp number in the FAP colon.

Citing Articles

First Evidence of Familial Transmission of Hereditary Gastrointestinal Polyposis Associated with Germline Variant in Jack Russell Terriers.

Yoneji W, Yoshizaki K, Hirota T, Yoneji K, Yoshikawa R, Mori T Vet Sci. 2023; 10(7).

PMID: 37505844 PMC: 10385476. DOI: 10.3390/vetsci10070439.

CD36 polymorphisms and the age of disease onset in patients with pathogenic variants within the mutation cluster region of APC.

Connor T, McPhillips M, Hipwell M, Ziolkowski A, Oldmeadow C, Clapham M Hered Cancer Clin Pract. 2021; 19(1):25.

PMID: 33926505 PMC: 8086281. DOI: 10.1186/s13053-021-00183-0.

Aggressive mutation in a familial adenomatous polyposis syndrome family: when phenotype guides clinical surveillance.

Neffa F, Garcia L, Della Valle A, Carusso F, Vergara C, Sanchez D J Gastrointest Oncol. 2018; 9(3):553-559.

PMID: 29998021 PMC: 6006030. DOI: 10.21037/jgo.2017.10.06.

Novel mutations and phenotypic associations identified through APC, MUTYH, NTHL1, POLD1, POLE gene analysis in Indian Familial Adenomatous Polyposis cohort.

Khan N, Lipsa A, Arunachal G, Ramadwar M, Sarin R Sci Rep. 2017; 7(1):2214.

PMID: 28533537 PMC: 5440391. DOI: 10.1038/s41598-017-02319-6.

The genetic basis of colonic adenomatous polyposis syndromes.

Talseth-Palmer B Hered Cancer Clin Pract. 2017; 15:5.

PMID: 28331556 PMC: 5353802. DOI: 10.1186/s13053-017-0065-x.

References

Smelt V, Mardon H, Sim E . Placental expression of arylamine N-acetyltransferases: evidence for linkage disequilibrium between NAT1*10 and NAT2*4 alleles of the two human arylamine N-acetyltransferase loci NAT1 and NAT2. Pharmacol Toxicol. 1998; 83(4):149-57. DOI: 10.1111/j.1600-0773.1998.tb01461.x. View

van der Put N, Gabreels F, STEVENS E, Smeitink J, Trijbels F, Eskes T . A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?. Am J Hum Genet. 1998; 62(5):1044-51. PMC: 1377082. DOI: 10.1086/301825. View

Rosenblatt D, Whitehead V . Cobalamin and folate deficiency: acquired and hereditary disorders in children. Semin Hematol. 1999; 36(1):19-34. View

Heinimann K, Scott R, Chappuis P, Weber W, Muller H, Dobbie Z . N-acetyltransferase 2 influences cancer prevalence in hMLH1/hMSH2 mutation carriers. Cancer Res. 1999; 59(13):3038-40. View

Lamlum H, Ilyas M, Rowan A, Clark S, Johnson V, Bell J . The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesis. Nat Med. 1999; 5(9):1071-5. DOI: 10.1038/12511. View

Hein D, Doll M, Fretland A, Leff M, Webb S, Xiao G . Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev. 2000; 9(1):29-42. View

Kong S, Amos C, Luthra R, Lynch P, Levin B, Frazier M . Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer. Cancer Res. 2000; 60(2):249-52. View

Scott E, Wright R . Variability of glutathione S-transferase of human erythrocytes. Am J Hum Genet. 1980; 32(1):115-7. PMC: 1685928. View

Board P, Coggan M, Johnston P, ROSS V, Suzuki T, Webb G . Genetic heterogeneity of the human glutathione transferases: a complex of gene families. Pharmacol Ther. 1990; 48(3):357-69. DOI: 10.1016/0163-7258(90)90054-6. View

10.

Board P, Johnston P, Ross V, Webb G, Coggan M, Suzuki T . Molecular genetics of the human glutathione S-transferase. Princess Takamatsu Symp. 1990; 21:199-211. View

11.

Fryer A, Zhao L, Alldersea J, Boggild M, Perrett C, Clayton R . The glutathione S-transferases: polymerase chain reaction studies on the frequency of the GSTM1 0 genotype in patients with pituitary adenomas. Carcinogenesis. 1993; 14(4):563-6. DOI: 10.1093/carcin/14.4.563. View

12.

Paul P, Letteboer T, Gelbert L, Groden J, White R, Coppes M . Identical APC exon 15 mutations result in a variable phenotype in familial adenomatous polyposis. Hum Mol Genet. 1993; 2(7):925-31. DOI: 10.1093/hmg/2.7.925. View

13.

Dietrich W, Lander E, Smith J, Moser A, Gould K, Luongo C . Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell. 1993; 75(4):631-9. DOI: 10.1016/0092-8674(93)90484-8. View

14.

Pemble S, SCHROEDER K, Spencer S, Meyer D, Hallier E, Bolt H . Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J. 1994; 300 ( Pt 1):271-6. PMC: 1138152. DOI: 10.1042/bj3000271. View

15.

Nugent K, Phillips R, Hodgson S, Cottrell S, Smith-Ravin J, Pack K . Phenotypic expression in familial adenomatous polyposis: partial prediction by mutation analysis. Gut. 1994; 35(11):1622-3. PMC: 1375624. DOI: 10.1136/gut.35.11.1622. View

16.

MacPhee M, Chepenik K, Liddell R, Nelson K, Siracusa L, Buchberg A . The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia. Cell. 1995; 81(6):957-66. DOI: 10.1016/0092-8674(95)90015-2. View

17.

Bell D, STEPHENS E, Castranio T, Umbach D, Watson M, Deakin M . Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Cancer Res. 1995; 55(16):3537-42. View

18.

Frosst P, Blom H, Milos R, Goyette P, Sheppard C, Matthews R . A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995; 10(1):111-3. DOI: 10.1038/ng0595-111. View

19.

Bell D, Badawi A, Lang N, Ilett K, Kadlubar F, Hirvonen A . Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue. Cancer Res. 1995; 55(22):5226-9. View

20.

Debinski H, Love S, Spigelman A, Phillips R . Colorectal polyp counts and cancer risk in familial adenomatous polyposis. Gastroenterology. 1996; 110(4):1028-30. DOI: 10.1053/gast.1996.v110.pm8612989. View